EX-2.1
from S-1
91 pages
Agreement and Plan of Merger and Reorganization Dated as of December 11, 2020 by and Among Turnstone Biologics Corp., Flatiron Merger Sub I, Inc., Flatiron Merger Sub II, LLC, Myst Therapeutics, Inc., and Timothy Langer, Solely in His Capacity as Equityholders Representative
12/34/56
EX-2.1
from DRS
91 pages
Agreement and Plan of Merger and Reorganization Dated as of December 11, 2020 by and Among Turnstone Biologics Corp., Flatiron Merger Sub I, Inc., Flatiron Merger Sub II, LLC, Myst Therapeutics, Inc., and Timothy Langer, Solely in His Capacity as Equityholders Representative
12/34/56
